<code id='CD8670857D'></code><style id='CD8670857D'></style>
    • <acronym id='CD8670857D'></acronym>
      <center id='CD8670857D'><center id='CD8670857D'><tfoot id='CD8670857D'></tfoot></center><abbr id='CD8670857D'><dir id='CD8670857D'><tfoot id='CD8670857D'></tfoot><noframes id='CD8670857D'>

    • <optgroup id='CD8670857D'><strike id='CD8670857D'><sup id='CD8670857D'></sup></strike><code id='CD8670857D'></code></optgroup>
        1. <b id='CD8670857D'><label id='CD8670857D'><select id='CD8670857D'><dt id='CD8670857D'><span id='CD8670857D'></span></dt></select></label></b><u id='CD8670857D'></u>
          <i id='CD8670857D'><strike id='CD8670857D'><tt id='CD8670857D'><pre id='CD8670857D'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:468
          WuXi AppTec company logo on a phone screen against a backgroud showing stock graph — coverage from STAT
          Adobe

          WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

          Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

          advertisement

          But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Life sciences investors close nearly $6 billion in new funds
          Life sciences investors close nearly $6 billion in new funds

          AdobeBiotechandlifesciencesinvestorscontinuetodrawinnewfundsevenasthebiotechstockindexesreachnewlows

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          3 questions for the future of Biden's cancer moonshot

          PresidentJoeBidenEliseAmendola/APWASHINGTON—ThelatestphaseofPresidentBiden’sCancerMoonshotinitiative